Vancouver Convention Centre

Disruption for Reconciliation in Action: AI Adoption as a Pathway to Inclusion

Retrieved on: 
星期一, 五月 27, 2024
Enbridge, Data governance, Interview, Digital, Ethics, Digital divide, Accreditation, Secwépemc, LNG Canada, Vancouver Convention Centre, IPSS, TELUS, Mining

Christy Morgan, Reconciliation Strategy Manager at TELUS and panel moderator, highlighted the need for systemic solutions.

Key Points: 
  • Christy Morgan, Reconciliation Strategy Manager at TELUS and panel moderator, highlighted the need for systemic solutions.
  • TELUS is the first and only company in Canada to publicly commit to incorporating Indigenous perspectives into their AI and data ethics strategy.
  • These technologies affect everyone, and meaningful inclusion matters," said Justin Watts, a software engineer who leads AI strategy at TELUS.
  • The panel discussion is part of the broader conference theme, "Reconciliation in Action," which aims to foster real-world applications of reconciliation through partnerships.

Indigenous Partnerships Success Showcase Returns for Milestone Fifth Year

Retrieved on: 
星期三, 五月 15, 2024
Enbridge, Interview, Digital, Government, Accreditation, Vancouver Convention Centre, LNG Canada, IPSS, Natural Resources, TELUS

VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- The Indigenous Partnerships Success Showcase (IPSS), a premier platform for celebrating Indigenous success, fostering partnerships and promoting sustainable development, is returning to Vancouver on June 5-6.

Key Points: 
  • VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) -- The Indigenous Partnerships Success Showcase (IPSS), a premier platform for celebrating Indigenous success, fostering partnerships and promoting sustainable development, is returning to Vancouver on June 5-6.
  • IPSS unites leaders in Indigenous business, government, and corporate Canada to highlight the ways these leading-edge relationships are making reconciliation a reality for the whole nation.
  • Celebrating its fifth year, the 2024 showcase will take place on June 5 – 6 at the Vancouver Convention Centre (West Building).
  • For more information, to book an interview or to apply for media accreditation, please contact Taylor Jantzi ([email protected]).

Blender Bites to Attend TED2024 as InKind Smoothie Bar Partner

Retrieved on: 
星期三, 四月 10, 2024
Jeff Bezos, Nonprofit organization, Courage, WKN, Education, Health, Thought, Partnership, FWB, Research, Air Canada, Marketing, Creativity, Blender, BITE, Vancouver Convention Centre

VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Blender Bites Limited (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), a multi award-winning Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is pleased to announce its participation as the InKind Smoothie Bar Partner at the upcoming TED2024.

Key Points: 
  • VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Blender Bites Limited (the “Company”, “Blender Bites” or “Blender”), (CSE: BITE, FWB: JL4, WKN: A3DMEJ), a multi award-winning Canadian company involved in the development and marketing of a line of premium, organic and plant-based pre-portioned frozen functional foods, is pleased to announce its participation as the InKind Smoothie Bar Partner at the upcoming TED2024.
  • This prestigious event can significantly enhance the visibility and reach of the Blender Bites brand and its innovative products, offering unparalleled exposure at one of the most influential gatherings on the global stage.
  • “We are thrilled to partner with TED2024 and contribute to an event that has been at the forefront of sharing transformative ideas,” said Chelsie Hodge, Blender Bites CEO and Founder.
  • “This partnership represents a remarkable opportunity for Blender Bites to showcase our commitment to health, wellness, and sustainable living to a global audience of thought leaders and innovators.

CANADIAN GEOGRAPHIC AND FRIENDS PLANT GUERRILLA MINI-FOREST ON THE DOORSTEP OF GLOBE FORUM CONVENTION IN VANCOUVER

Retrieved on: 
星期二, 二月 13, 2024
Soil, Vancouver Convention Centre, City, Associate, Smoke, Biodiversity, Toronto-Dominion Bank, Carbon, Climate change, Network, Tree, Organization, Canadian Geographic, Research, Partnership, Forestry

VANCOUVER, BC, Feb. 13, 2024 /CNW/ - A remarkably powerful and timely innovation in urban forestry – the mighty Mini-Forest will be planted outside the Globe Forum at the Vancouver Convention Centre this week.

Key Points: 
  • VANCOUVER, BC, Feb. 13, 2024 /CNW/ - A remarkably powerful and timely innovation in urban forestry – the mighty Mini-Forest will be planted outside the Globe Forum at the Vancouver Convention Centre this week.
  • Canadian Geographic and the Network of Nature partners are advocating for the  establishment of these tiny forests in demonstration plots in communities across Canada.
  • "With our Network of Nature partners we are thrilled to be planting a demonstration Mini-Forest today on the doorstep of this regeneration-themed sustainability conference, GLOBE Forum 2024," said Aran O'Carroll, Director, Environment, Canadian Geographic.
  • The conference is being convened in downtown Vancouver at the Vancouver Convention Centre, Feb 13-15.

WWF-Canada and Aviva Canada launch free resource for Canadian businesses to take urgent action to protect biodiversity

Retrieved on: 
星期二, 二月 6, 2024
Nature, Senior, GDP, Biodiversity, Aviva Canada, Sustainability, Climate change, Biodiversity action plan, Climate, WWF-Canada, Corporate Affairs, Action plan, Biodiversity loss, Social impact, Hockey, Health, PwC, Insurance, Vancouver Convention Centre, Business, Agriculture

Stakeholders of all types — from investors to suppliers to customers — are starting to demand that businesses contribute to a healthy natural world.

Key Points: 
  • Stakeholders of all types — from investors to suppliers to customers — are starting to demand that businesses contribute to a healthy natural world.
  • In tandem with urgent decarbonization, it is time for all businesses to act to protect nature.
  • The Business and Biodiversity Action Plan supports this need by providing a practical, phased approach that business leaders can action immediately.
  • Our Action Plan, Business and Biodiversity: Your Company's Path Towards Nature-Positivity, is available at wwf.ca/actionplan

Indigenous Partnerships Success Showcase celebrates five years of bringing together Indigenous leaders, government and business innovators, returning on June 5 & 6, 2024

Retrieved on: 
星期一, 十二月 11, 2023
First Nations, Policy, TELUS, Goldman Sachs, Natural Resources, Government, Telecommunications, Digital, IPSS, Musqueam Indian Band, Vancouver Convention Centre, Entrepreneurship

VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The Indigenous Partnerships Success Showcase (IPSS), a premier platform for celebrating Indigenous success, fostering partnerships and promoting sustainable development, returns June 5 and 6, 2024.

Key Points: 
  • VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The Indigenous Partnerships Success Showcase (IPSS), a premier platform for celebrating Indigenous success, fostering partnerships and promoting sustainable development, returns June 5 and 6, 2024.
  • The theme for the fifth annual Vancouver-based conference is “Reconciliation in Action.” GCT Global Container Terminals is returning as the event’s patron sponsor, alongside digital sponsor TELUS.
  • Registration for this signature event is now available at an early bird rate of 15% off the regular ticket price (offer ends February 1, 2024).
  • “I encourage business and government leaders to join me at IPSS 2024 to celebrate that success and discover new ways to take action on reconciliation."

Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting

Retrieved on: 
星期五, 十一月 10, 2023
Biotechnology, Other Health, Health, General Health, Pharmaceutical, Oncology, Neurology, Other Science, Research, Science, Clinical Trials, CNS, Neoplasm, Vancouver Convention Centre, Safety, Annual general meeting, PST, Quality, Radiosurgery, Pakistan Society of Neuro-Oncology, Barrier, American Brain Tumor Association, TRIDENT, GBM, Chemoradiotherapy, Patient, TMZ, TTF, Radiation, Alternating electric field therapy, Quality of life, Lung cancer, Neuro, Biomarker, Trial of the century, METIS, Survival, TIGER, Central nervous system, Immunotherapy, Skin, Oligodendroglioma, SNO, NSCLC, Medical imaging, Pharmaceutical industry, Communications satellite, Glioblastoma

The 2023 SNO Annual Meeting will also mark the debut of Novocure’s new Optune Gio™ brand.

Key Points: 
  • The 2023 SNO Annual Meeting will also mark the debut of Novocure’s new Optune Gio™ brand.
  • Long-term global post-marketing surveillance data from pediatric, adult and elderly patients with central nervous system malignancies treated with Tumor Treating Fields (TTFields) therapy.
  • 7:30 p.m. PST on Friday, Nov. 17
    Adopting Tumor Treating Fields (TTFields) therapy for glioblastoma and other solid cancers: challenges and opportunities.
  • 7:30 p.m. PST on Friday, Nov. 17
    Development of Tumor Treating Fields (TTFields) arrays for treatment of head tumors in mice models.

AM-Pharma Announces Positive Clinical Data From Phase 1b Study Evaluating Ilofotase Alfa in Hypophosphatasia Patients

Retrieved on: 
星期三, 十月 11, 2023
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Bone disease, Vancouver Convention Centre, Pharmacokinetics, Doctor of Philosophy, Biomarker, MD, Society, Data, DSM-IV codes, PLP, Safety, University, ALPL, Disease, Arthropathy, Patient, HPP, PDT, Enzyme, Pyrophosphate, Hypophosphatasia, American Society for Bone and Mineral Research, Muscle weakness, Enzyme replacement therapy, Pharmaceutical industry

AM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacement therapy in adult hypophosphatasia (HPP) patients.

Key Points: 
  • AM-Pharma B.V. today announced positive clinical results from the Phase 1b study evaluating the company’s proprietary recombinant alkaline phosphatase, ilofotase alfa, as potential enzyme replacement therapy in adult hypophosphatasia (HPP) patients.
  • Patients were followed for 10 days after dosing to evaluate changes in the biochemical fingerprint of HPP, safety and tolerability.
  • In addition, ilofotase alfa was well-tolerated with pharmacokinetics consistent with observations from previous clinical studies.
  • "The encouraging early results confirming dose-dependent reductions of PLP and PPi levels upon treatment with ilofotase alfa underline the compound's therapeutic potential in that indication and I'm looking forward to evaluating ilofotase alfa in next stage clinical studies."

Bold Therapeutics Selected as 2023 'Company to Watch' by Life Sciences British Columbia

Retrieved on: 
星期四, 九月 14, 2023
LSBC, Vancouver Convention Centre, AACR, Friends, EVP, ASCO, Bayer, Patient, Emphasis (typography), Preclinical development, Trifluridine, CIO, Biliary tract, Therapy, Safety, Pharmaceutical industry

VANCOUVER, BC, Sept. 14, 2023 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, is announcing its selection by Life Sciences British Columbia (LSBC) for the 2023 'Company to Watch' Honour Roll.

Key Points: 
  • VANCOUVER, BC, Sept. 14, 2023 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, is announcing its selection by Life Sciences British Columbia (LSBC) for the 2023 'Company to Watch' Honour Roll.
  • This year marks the 25th Annual Life Sciences BC Awards that brings together industry leaders, researchers, investors, and stakeholders to celebrate their remarkable achievements.
  • The ceremony will provide an opportunity to showcase the cutting-edge research, technological advancements, and collaborations that drive innovation in British Columbia's thriving life sciences community and takes place on September 14, 2023 at the Vancouver Convention Centre.
  • Bold Therapeutics' BOLD-100 is a first-in-class metallotherapeutic with a unique multimodal mechanism-of-action.

RecycLiCo Battery Materials Inc. to Participate in Fully Charged LIVE Canada Show 2023

Retrieved on: 
星期二, 八月 22, 2023
Canada, Vancouver Convention Centre, Sandy Munro, WSP, Recycling, Fully Charged, Fully, Associate, Charge density, Electric battery

VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or “Company”), a battery materials company focused on lithium-ion battery recycling and upcycling, is pleased to announce its involvement in the Fully Charged LIVE Canada Show - The World’s No.

Key Points: 
  • VANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- RecycLiCo Battery Materials Inc. (“RecycLiCo” or “Company”), a battery materials company focused on lithium-ion battery recycling and upcycling, is pleased to announce its involvement in the Fully Charged LIVE Canada Show - The World’s No.
  • This marks the second time RecycLiCo has taken part in a Fully Charged event, and it's notable that this year’s event is the first time Fully Charged Canada is being hosted in Vancouver, BC.
  • In addition, RecycLiCo Battery Materials is offering a 50% discount on ticket prices for those interested in attending the event.
  • For more information on Fully Charged LIVE and the various panel discussions, please click here .